Senseonics Holdings, Inc.

Stage 2 · Advancing · week 7

As of Oct 22, 2026, Senseonics Holdings is in Stage 2, the uptrend phase, now in week 7 (since Sep 3, 2026). It closed at $7.40, 28.4% below its 52-week high and above its 200-day average, which is rising.

$7.40

-7.15% today

$391M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is SENS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 14w

S4 36w

S4 30w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 14w → S1 10w → S4 4w → S1 5w → S4 36w → S1 3w → S2 11w → S3 13w → S4 30w → S1 9w → S4 10w → S1 3w → S4 7w → S1 2w → S2 7w current

Total tracked: 165 weeks across 16 stage runs.

SENS among Medical Devices48th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…48	SENSSenseonics Holdings, Inc.	Stage 2 · wk 7	52	−25.8%

vs 52W High

-28.4%

$4.86 lo$10.34 hi

28.4% below 52W high, far from high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 7

1w13w26w

Week 7, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

3.4%

200 DMA: $7.16 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.79x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-25.8%

+52.3%

+5.7%

YTD

+25.6%

-3.0%

Scan Membership

Breakout Watch

Latest: 2025-01-16

4 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 7 · Vol 0.79x

2026-10-21S2

Wk 7 · Vol 0.62x

2026-10-20S2

Wk 7 · Vol 0.51x

2026-10-19S2

Wk 7 · Vol 0.55x

2026-10-16S2

Wk 7 · Vol 0.81x

2026-10-15S2

Wk 6 · Vol 0.90x

2026-10-14S2

Wk 6 · Vol 0.98x

2026-10-13S2

Wk 6 · Vol 0.70x

2026-10-12S2

Wk 6 · Vol 0.61x

2026-10-09S2

Wk 6 · Vol 0.67x

2026-10-08S2

Wk 5 · Vol 1.04x

2026-10-07S2

Wk 5 · Vol 0.87x

Moving averages & range

50 DMA

$9.15

200 DMA

$7.16

52W High

$10.34

52W Low

$4.86

5D Low

$7.40

Resistance levels (recent highs)

20d High

$10.31

60d High

$10.34

120d High

$10.34

250d High

$10.34

Next resistance

+39.3%

to 20d High

ROE

-118.2%

Profit margin -225.3%

Dividend Yield

0.00%

P/B 4.3

Senseonics Holdings: quick answers

What stage is Senseonics Holdings in?

As of Oct 22, 2026, Senseonics Holdings (SENS) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 3, 2026 and is in week 7. What the four stages mean

Is Senseonics Holdings in an uptrend?

Yes. Senseonics Holdings is in a Stage 2 uptrend. It trades 3.4% above its 200-day average, which is rising.

How far is Senseonics Holdings from its 52-week high?

Senseonics Holdings closed at $7.40 on Oct 22, 2026, 28.4% below its 52-week high of $10.34. Its 52-week low is $4.86.

How has Senseonics Holdings performed over the past year?

As of Oct 22, 2026, Senseonics Holdings is down 3.0% over the past year and up 25.6% so far in 2026.

Which sector and industry is Senseonics Holdings in?

Senseonics Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.